Form 4 · Filed Jun 24, 2026, 08:16 PM UTC
CNTA/Centessa Pharmaceuticals plc
De Rubertis Francesco — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
6 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 24, 2026 | D | other | 4,398,519 | — | — | 0 |
| Jun 24, 2026 | D | other | 55,677 | — | — | 0 |
| Jun 24, 2026 | D | other | 3,936,970 | — | — | 0 |
| Jun 24, 2026 | D | other | 93,526 | — | — | 0 |
| Jun 24, 2026 | D | other | 11,197,303 | — | — | 0 |
| Jun 24, 2026 | D | other | 281,162 | — | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0001470831-26-000615